Nanoco Group PLC, a leader in cadmium-free quantum dots and nanomaterials, has announced that Dr. Christopher Richards, Non-Executive Chairman, along with Brian Tenner, Chief Executive Officer, and Liam Gray, Chief Financial Officer, have collectively purchased 259,550 ordinary shares in the company. The transactions were made in accordance with the EU Market Abuse Regulation and further details of the transactions have been provided.
Nanoco, listed on the Main Market of the London Stock Exchange, specializes in patented cadmium-free quantum dots and other nano-materials for use in the electronics industries. The company was founded in 2001 and is headquartered in Runcorn, UK. Nanoco's quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, making them suitable for a wide range of display applications. The company continues to build a world-class, patent-protected IP portfolio alongside scaling production for commercial orders.
The recent share purchases by the company's key personnel demonstrate their confidence in Nanoco's future and its technology platform. The transactions were made on the London Stock Exchange, with Dr. Christopher Richards purchasing 99,755 shares at a price of 20.03, Mrs. Claire Deruty purchasing 85,324 shares at a price of 19.92, and Liam Gray purchasing 74,471 shares at a price of 20.14.
These transactions reflect the commitment of Nanoco's leadership to the company's growth and development, and they serve as a positive indicator of the company's prospects in the quantum dot and nanomaterials market. For further information, interested parties can contact the company's CFO & Company Secretary, Liam Gray, at the provided telephone number or visit Nanoco's official website.